Pituitary gigantism treated successfully with the growth hormone receptor antagonist, pegvisomant [Letter]

Daniel, A., D'Emden, Michael, & (2013) Pituitary gigantism treated successfully with the growth hormone receptor antagonist, pegvisomant [Letter]. Internal Medicine Journal, 43(3), pp. 345-347.

View at publisher

Description

A Caucasian male aged 15 years presented with 2 years accelerated linear growth. He was 202 cm tall at presentation, with calculated mid-parental height of 173 cm. There were no features of hypopituitarism or acral growth. His visual fields and optic discs were normal...

Impact and interest:

4 citations in Scopus
3 citations in Web of Science®
Search Google Scholar™

Citation counts are sourced monthly from Scopus and Web of Science® citation databases.

These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.

Citations counts from the Google Scholar™ indexing service can be viewed at the linked Google Scholar™ search.

ID Code: 94206
Item Type: Contribution to Journal (Letter)
Refereed: No
ORCID iD:
Duncan, Emmaorcid.org/0000-0002-8143-4403
Additional Information: Letter
Measurements or Duration: 3 pages
Keywords: Hormone Antagonists, Human Growth Hormone, Humans, Membrane Proteins, Treatment Outcome, adolescent, androgen therapy, angiopeptin, clinical article, gigantism, growth plate, human, hypophysis adenoma, hypophysis disease, letter, male, nuclear magnetic resonance imaging, pegvisomant, pituitary gigantism, priority journal, somatomedin C
DOI: 10.1111/imj.12077
ISSN: 1445-5994
Pure ID: 34522113
Divisions: Past > QUT Faculties & Divisions > Faculty of Health
Past > Institutes > Institute of Health and Biomedical Innovation
Copyright Owner: Consult author(s) regarding copyright matters
Copyright Statement: This work is covered by copyright. Unless the document is being made available under a Creative Commons Licence, you must assume that re-use is limited to personal use and that permission from the copyright owner must be obtained for all other uses. If the document is available under a Creative Commons License (or other specified license) then refer to the Licence for details of permitted re-use. It is a condition of access that users recognise and abide by the legal requirements associated with these rights. If you believe that this work infringes copyright please provide details by email to qut.copyright@qut.edu.au
Deposited On: 29 Mar 2016 00:35
Last Modified: 31 Mar 2024 13:44